Researchers at the Institute for Bioengineering of Catalonia (IBEC) have created the world’s simplest artificial cell capable of chemical navigation, migrating toward specific substances like living cells do.

This breakthrough, published in Science Advances, demonstrates how microscopic bubbles can be programmed to follow chemical trails. The study describes the development of a “minimal cell” in the form of a lipid vesicle encapsulating enzymes that can propel itself through chemotaxis.

Cellular transport is a vital aspect of many biological processes and a key milestone in evolution. Among all types of movement, chemotaxis is an essential strategy used by many living systems to move towards beneficial signals, such as nutrients, or away from harmful ones.

This is a sci-fi documentary looking at the future of genetic engineering and how it applies to space exploration, astronauts, terraforming planets and even Earth.

What is DNA, and how can it be engineered. What is CRISPR, and the future technology used in genetic engineering and biotechnology.

Personal inspiration in creating this video came from: Jurassic Park (the book), and The Expanse TV show (the protomolecule).

Other topics in the video include: how genetic engineering can change food allergies, cryosleep astronauts using hibernation biology borrowed from bears, squirrels and hedgehogs, engineering plants for terraforming other planets, and entries from The Encyclopedia of the Future.

PATREON
The third volume of ‘The Encyclopedia of the Future’ is now available on my Patreon.

Visit my Patreon here: https://www.patreon.com/venturecity.

Researchers from Columbia Engineering have established a framework for the design of bioactive injectable hydrogels formulated with extracellular vesicles (EVs) for tissue engineering and regenerative medicine applications.

Published in Matter, Santiago Correa, assistant professor of biomedical engineering at Columbia Engineering, and his collaborators describe an injectable hydrogel platform that uses EVs from milk to address longstanding barriers in the development of biomaterials for regenerative medicine.

EVs are particles naturally secreted by cells and carry hundreds of biological signals, like proteins and genetic material, enabling sophisticated cellular communication that synthetic materials cannot easily replicate.

Explores the groundbreaking world of 3D bioprinting in regenerative medicine, where custom organs printed layer-by-layer from human cells are transforming transplantation. In this video, we uncover the latest advances in bioprinting technology, from biocompatible bioinks to vascularized tissue scaffolds that mimic natural organ architecture.

Dive into the science behind printing life as we showcase flagship projects: a beating mini heart engineered with human cardiomyocytes; 3D-printed liver organoids that perform metabolic functions; and personalized kidney scaffolds seeded with patient-derived stem cells. Learn how bio-printed skin grafts with integrated blood vessels accelerate wound healing and reduce scarring and discover innovations in printing complex structures like pancreas and lung tissue.

We break down key techniques—extrusion-based bioprinting, stereolithographic printing, and sacrificial ink methods—that enable high-resolution, cell-friendly constructs. Our experts explain challenges in tissue vascularization, bioink formulation, and regulatory pathways for clinical use. Gain insights into clinical trials driving the future of organ transplants without donor shortages.

Whether you’re a biotech researcher or tech enthusiast, this video offers insights and case studies. Don’t miss this cutting-edge guide to 3D bio-printed organs and tissue engineering.

#techforgood #futureofmedicine #aiinhealthcare #medicalai #bioprinting #tissueengineering #explainervideo #scienceexplained

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to clear pathological tau protein from the brains of patients suffering from Alzheimer’s dementia.

The Phase 1a/1b trial, supported in part by a $1 million grant from the Alzheimer’s Association’s Part the Cloud initiative, will test the novel vaccine, which was developed by UNM School of Medicine scientists, said Kiran Bhaskar, PhD, professor in the Departments of Molecular Genetics & Microbiology and Neurology.

“The primary endpoint of this study is safety and tolerability,” he said. “Can these subjects take these vaccinations without any anticipated side effects or adverse events? The second endpoint is the immunogenicity – can they make antibodies to tau?”

See relevant content for m.

A new study reveals how CRISPR gene editing could potentially eradicate Down syndrome.

4k words, 19 minutes reading time

As bioelectronics merge with tissue engineering, bioengineered organs are gaining the ability to sense, respond, and adapt in real time—ushering in a new era of smart regenerative systems.

Gene editing technologies—such as those used in agriculture and de-extinction projects—can be repurposed to offer what an international team of scientists is calling a transformative solution for restoring genetic diversity and saving endangered species.